miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2

Mohamed, Z., Hassan, M.K., Okasha, S. et al. (7 more authors) (2018) miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2. Oncotarget, 9 (53). pp. 30053-30065.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: Mohamed et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: LATS2; chemoresistance; miR-363; ovarian cancer; taxane
Dates:
  • Accepted: 4 June 2018
  • Published: 10 July 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > School of Biological Sciences (Sheffield) > Department of Molecular Biology and Biotechnology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 15 Oct 2018 14:25
Last Modified: 15 Oct 2018 14:25
Published Version: https://doi.org/10.18632/oncotarget.25698
Status: Published online
Publisher: Impact Journals
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.25698
Related URLs:

Share / Export

Statistics